UK markets closed
NIKKEI 225
38,179.46 -49.65 (-0.13%) HANG SENG
19,115.06 +151.38 (+0.80%) CRUDE OIL
79.24 +0.98 (+1.25%) GOLD FUTURES
2,343.90 -31.10 (-1.31%) DOW
39,431.64 -81.20 (-0.21%) Bitcoin GBP
50,260.84 +1,366.40 (+2.79%)
Ningbo David Medical Device Co., Ltd. (300314.SZ)
Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
At close: 03:04PM CST
Currency in CNY
Valuation measures4
| Market cap (intra-day) | 3.63B |
| Enterprise value | 2.92B |
| Trailing P/E | 26.93 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.93 |
| Price/book (mrq) | 3.03 |
| Enterprise value/revenue | 8.37 |
| Enterprise value/EBITDA | 40.10 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.11 |
| 52-week change 3 | -38.68% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 22.63 |
| 52-week low 3 | 8.23 |
| 50-day moving average 3 | 11.48 |
| 200-day moving average 3 | 13.82 |
Share statistics
| Avg vol (3-month) 3 | 5.7M |
| Avg vol (10-day) 3 | 11.35M |
| Shares outstanding 5 | 288M |
| Implied shares outstanding 6 | 290.64M |
| Float 8 | 93.8M |
| % held by insiders 1 | 66.79% |
| % held by institutions 1 | 6.42% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.15 |
| Forward annual dividend yield 4 | 1.09% |
| Trailing annual dividend rate 3 | 0.18 |
| Trailing annual dividend yield 3 | 1.43% |
| 5-year average dividend yield 4 | 0.83 |
| Payout ratio 4 | 32.01% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 09 May 2023 |
| Last split factor 2 | 18:10 |
| Last split date 3 | 20 May 2015 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 22.04% |
| Operating margin (ttm) | 28.55% |
Management effectiveness
| Return on assets (ttm) | 5.59% |
| Return on equity (ttm) | 11.75% |
Income statement
| Revenue (ttm) | 615.76M |
| Revenue per share (ttm) | 2.13 |
| Quarterly revenue growth (yoy) | -1.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 141.57M |
| Net income avi to common (ttm) | 135.7M |
| Diluted EPS (ttm) | 0.47 |
| Quarterly earnings growth (yoy) | -23.80% |
Balance sheet
| Total cash (mrq) | 726.52M |
| Total cash per share (mrq) | 2.52 |
| Total debt (mrq) | 12.24M |
| Total debt/equity (mrq) | 1.02% |
| Current ratio (mrq) | 6.42 |
| Book value per share (mrq) | 4.17 |
Cash flow statement
| Operating cash flow (ttm) | 117.96M |
| Levered free cash flow (ttm) | -7.76M |
© 2024 Yahoo. All rights reserved.